What are the treatment options for female urinary incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Female Urinary Incontinence

The treatment approach for female urinary incontinence depends critically on the type of incontinence: pelvic floor muscle training (PFMT) is first-line for stress incontinence, bladder training is first-line for urgency incontinence, and both PFMT plus bladder training are recommended for mixed incontinence. 1

Initial Assessment and Classification

Before initiating treatment, determine the specific type of urinary incontinence:

  • Stress urinary incontinence (SUI): Urine loss with coughing, sneezing, laughing, or physical exertion due to urethral sphincter failure 1
  • Urgency urinary incontinence (UUI): Involuntary urine loss associated with a sudden compelling urge to void 1
  • Mixed urinary incontinence (MUI): Combination of both stress and urgency symptoms 1

Rule out urinary tract infection and hematuria before proceeding with treatment 2

Treatment Algorithm by Type

Stress Urinary Incontinence

First-Line Treatment:

  • Initiate supervised pelvic floor muscle training (PFMT) as the primary intervention - this is supported by high-quality evidence showing PFMT is more than 5 times as effective as no treatment and can reduce incontinence episodes by more than 50% 1, 3
  • PFMT should involve repeated voluntary pelvic floor muscle contractions (Kegel exercises) taught and supervised by a healthcare professional, not unsupervised home exercises 3
  • More intensive PFMT with greater individual supervision is more effective than less-intensive programs 4
  • Consider adding biofeedback using vaginal EMG to provide visual feedback on proper pelvic floor muscle contraction 1
  • Vaginal cones can be used as an alternative to PFMT, with moderate to high certainty evidence of benefit 4

Adjunctive Interventions:

  • For obese women, recommend weight loss and exercise - this has moderate-quality evidence showing significant symptom improvement 1, 3
  • Vaginal pessaries or urethral inserts can be considered, particularly when combined with PFMT 3, 5
  • Continence pessary plus PFMT is more beneficial than pessary alone 4

Critical Pitfall to Avoid:

  • Do NOT use systemic pharmacologic therapy for stress incontinence - the American College of Physicians strongly recommends against this based on lack of efficacy 1, 3

Surgical Options (if conservative measures fail):

  • Synthetic midurethral mesh slings are the most common surgical treatment, with symptom improvement in 48% to 90% of women and low mesh complication rates (<5%) 2
  • Other options include retropubic suspension and fascial slings 3

Urgency Urinary Incontinence

First-Line Treatment:

  • Begin with bladder training - this behavioral therapy involves scheduled voiding with progressively longer intervals between bathroom trips 1, 3
  • This is supported by strong recommendation with moderate-quality evidence 1
  • PFMT plus biofeedback is also effective for urgency incontinence 4
  • Electrical stimulation has moderate to high certainty evidence of benefit 4

Second-Line Pharmacologic Treatment (if bladder training unsuccessful):

  • Initiate anticholinergic medications or beta-3 agonists - all agents show similar effectiveness, so base selection on tolerability, adverse effect profile, ease of use, and cost rather than efficacy 1, 3
  • Effective anticholinergic options include: oxybutynin, tolterodine, darifenacin, solifenacin, fesoterodine, and trospium - all increase continence rates with moderate magnitude of benefit 3
  • Mirabegron (beta-3 agonist) at 50 mg daily reduces incontinence episodes by 0.34-0.42 episodes per 24 hours compared to placebo and reduces micturitions by 0.42-0.61 per 24 hours 6
  • Beta-3 agonists have fewer anticholinergic side effects compared to antimuscarinics 7

Critical Counseling Points:

  • Warn patients upfront about anticholinergic adverse effects including dry mouth, constipation, heartburn, urinary retention, and potential cognitive impairment - these are major reasons for treatment discontinuation 3, 5
  • Poor adherence to pharmacologic treatments is common due to side effects 3
  • Not all patients require pharmacotherapy if symptoms are mild and behavioral measures provide adequate relief 3

Third-Line Interventions (if conservative and pharmacologic therapies fail):

  • OnabotulinumtoxinA (Botox) injections 2, 5
  • Percutaneous tibial nerve stimulation 2, 5
  • Sacral nerve stimulators (surgically implanted) 5

Mixed Urinary Incontinence

First-Line Treatment:

  • Combine pelvic floor muscle training with bladder training - this has strong recommendation with moderate-quality evidence 1
  • PFMT plus bladder training is more beneficial than bladder training alone for both cure/improvement and quality of life 4
  • For obese women, prioritize weight loss - this benefits the stress component more than the urgency component 3

Second-Line Pharmacologic Treatment:

  • Solifenacin and fesoterodine are preferred choices as they demonstrate dose-response effects on symptom improvement, with modest benefit of less than 20% absolute risk difference versus placebo 3
  • Counsel about anticholinergic adverse effects including dry mouth, constipation, heartburn, and urinary retention 3

Surgical Intervention (if conservative measures fail):

  • Synthetic midurethral mesh slings can cure both stress and urge components in 40-50% of cases 3
  • Counsel about surgical complications including direct injury to lower urinary tract, hemorrhage, infection, bowel injury, wound complications, and mesh-specific complications 3

Universal Lifestyle Modifications

Regardless of incontinence type, recommend:

  • Adequate but not excessive fluid intake 3, 2
  • Regular voiding intervals to reduce urgency episodes 2
  • Avoidance of bladder irritants (caffeine, alcohol) 2
  • Treatment of chronic cough and constipation 1

Key Clinical Principles

  • Behavioral interventions (PFMT, bladder training) have no identified harms in studies, making them ideal first-line treatments 3
  • Clinically successful treatment is defined as reducing incontinence episodes by at least 50% 1, 3
  • Only 25% of women with incontinence seek or receive treatment despite many effective options available 2
  • Supervised PFMT is significantly more effective than unsupervised home exercises 3, 4
  • More intensive, frequent PFMT with individual supervision improves effectiveness 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urinary Incontinence in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of urinary incontinence in women.

American family physician, 2013

Research

Non-Surgical Management of Urinary Incontinence.

Journal of the American Board of Family Medicine : JABFM, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.